STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

GRAIL to Present at 7th Annual Wolfe Research Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

GRAIL (Nasdaq: GRAL) announced that company management will present at the 7th Annual Wolfe Research Healthcare Conference on Tuesday, Nov. 18, 2025 at 10:00 a.m. ET.

Live and replay webcasts will be available via the company's investor relations site at investors.grail.com, and the webcast will be archived and available for replay for at least 30 days after the event.

GRAIL (Nasdaq: GRAL) ha annunciato che la direzione dell'azienda terrà una presentazione alla 7ª Conferenza Annuale Wolfe Research Healthcare il martedì 18 novembre 2025 alle 10:00 ET.

Webcast in diretta e in replica saranno disponibili tramite il sito delle relazioni con gli investitori dell'azienda all'indirizzo investors.grail.com, e il webcast sarà archiviato e disponibile per la replica per almeno 30 giorni dopo l'evento.

GRAIL (Nasdaq: GRAL) anunció que la dirección de la empresa presentará en la 7ª Conferencia Anual Wolfe Research Healthcare el martes 18 de noviembre de 2025 a las 10:00 a.m. ET.

Webcasts en vivo y de repetición estarán disponibles a través del sitio de relaciones con inversores de la empresa en investors.grail.com, y el webcast será archivado y estará disponible para su reproducción durante al menos 30 días después del evento.

GRAIL (Nasdaq: GRAL) 은 회사 경영진이 제7회 Wolfe Research Healthcare Conference2025년 11월 18일 화요일 오전 10:00 동부표준시에 발표할 것이라고 발표했습니다.

라이브 및 재방송 웹캐스트는 회사의 투자자 관계 사이트 investors.grail.com를 통해 이용 가능하며, 웹캐스트는 이벤트 후 최소 30일간 보관되어 재생할 수 있습니다.

GRAIL (Nasdaq : GRAL) a annoncé que la direction de l'entreprise interviendra lors de la 7e conférence annuelle Wolfe Research Healthcare le mardi 18 novembre 2025 à 10h00 ET.

Webcasts en direct et en réplique seront disponibles via le site des relations investisseurs de l'entreprise à l'adresse investors.grail.com, et le webcast sera archivé et disponible en réplique pendant au moins 30 jours après l'événement.

GRAIL (Nasdaq: GRAL) hat bekannt gegeben, dass das Management des Unternehmens bei der 7. Wolfe Research Healthcare Conference am Dienstag, den 18. November 2025 um 10:00 Uhr ET auftreten wird.

Live- und Wiederholungs-Webcasts werden über die Investor-Relations-Website des Unternehmens unter investors.grail.com verfügbar sein, und der Webcast wird archiviert und für mindestens 30 Tage nach der Veranstaltung zur Wiedergabe verfügbar sein.

GRAIL (ناسداك: GRAL) أعلنت أن إدارة الشركة ستقدم عرضاً في المؤتمر الصحي السنوي السابع لشركة وولف ريسيرش يوم الثلاثاء، 18 نوفمبر 2025، الساعة 10:00 صباحاً بتوقيت شرق الولايات المتحدة ET.

البث المباشر وبثات الإعادة ستكون متاحة عبر موقع علاقات المستثمرين للشركة على العنوان investors.grail.com، وسيتم حفظ البث المباشر وإتاحة الإعادة لمدة لا تقل عن 30 يوماً بعد الحدث.

Positive
  • None.
Negative
  • None.

MENLO PARK, Calif., Nov. 4, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the 7th Annual Wolfe Research Healthcare Conference on Tuesday, Nov. 18 at 10:00 a.m. ET. 

Live and replay webcasts may be accessed in the investor relations section of GRAIL's website at investors.grail.com. The webcast will be archived and available for reply for at least 30 days after the event.

About GRAIL
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL's targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in Menlo Park, CA with locations in Washington, D.C., North Carolina, and the United Kingdom.

For more information, visit grail.com.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/grail-to-present-at-7th-annual-wolfe-research-healthcare-conference-302604500.html

SOURCE GRAIL, Inc.

FAQ

When will GRAIL (GRAL) present at the Wolfe Research Healthcare Conference?

GRAIL will present on Tuesday, Nov. 18, 2025 at 10:00 a.m. ET.

How can investors watch the GRAIL (GRAL) presentation on Nov. 18, 2025?

Investors can access the live webcast and replays via the investor relations site at investors.grail.com.

Will the GRAIL (GRAL) webcast be available after the Wolfe Research conference?

Yes, the webcast will be archived and available for replay for at least 30 days after the event.

Where on the GRAIL website will the Wolfe Research webcast appear?

The webcast will be posted in the Investor Relations section of investors.grail.com.

Is there any fee or special registration mentioned to view the GRAIL (GRAL) webcast?

No fee or special registration is mentioned; the announcement directs viewers to the investor relations site.

What time zone is used for the GRAIL (GRAL) conference presentation time?

The presentation time is shown in Eastern Time (ET).
Grail Inc

NASDAQ:GRAL

GRAL Rankings

GRAL Latest News

GRAL Latest SEC Filings

GRAL Stock Data

3.24B
31.07M
13.81%
73.53%
13.42%
Diagnostics & Research
Services-medical Laboratories
Link
United States
MENLO PARK